Clinical Diagnostics Market: Information by Type of Tests, Products, End-User (Hospital, Diagnostic Laboratory, Others) , and Region — Forecast till 2029

Apr 23, 2020   Market Overview Clinical diagnostics include medical tests carried out in pathology or diagnostic laboratory or hospital or in some other medical facility for the assessment or detection of any disease or other medical conditions. These clinical test results support in the early detection of illness and diagnose the associated risk factors while providing prevention and treatment prospects. The global market for clinical diagnostics is expected to grow at a considerable pace during the forecast...
Request Free Sample Report

Report Description

Market Overview

Clinical diagnostics include medical tests carried out in pathology or diagnostic laboratory or hospital or in some other medical facility for the assessment or detection of any disease or other medical conditions. These clinical test results support in the early detection of illness and diagnose the associated risk factors while providing prevention and treatment prospects. The global market for clinical diagnostics is expected to grow at a considerable pace during the forecast period. Clinical diagnostic testing includes all routine check-ups, and other pathological examinations for diagnosis of diseases, ranging from complete blood count (CBC) tests to anatomical, physiological, molecular, and immunological and drug testing for disease diagnosis and early treatment intervention.

The global clinical diagnostics market size was valued at USD 50,025 million in 2019 and is expected to expand at a CAGR of 6.5 % during the forecast period, 2020–2029.

Global-Clinical-Diagnostics-Market

Market Drivers

An Array of Clinical Tests  — The Market Driver

A wide variety of clinical tests strengthens the ability of health care professionals to diagnose disease progress and often include blood and urine testing ranging from simple to complex genetic testing of molecular expression and various biochemical testing. There are more than 4,000 diagnostic tests available today and have been categorized into lipid profiling, complete blood count, HbA1c tests, HGB/HCT, Creatinine estimation, liver profiling, electrolytes testing, allergy profile testing, basic and comprehensive metabolic tests, and renal profile tests. Clinical testing laboratories offer these tests and services to meet the needs of the medical industry.

The Prevalence of Chronic Diseases

The clinical diagnostics market is primarily driven by the increasing prevalence of diseases caused due to sedentary lifestyles such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, and others. Furthermore, an increase in the number of patients suffering from kidney diseases and cancer is also expected to impact positively on the clinical diagnostics market during the forecast years. Additionally, benefits such as quick test results, easy procedure of testing, ease of procurement of samples, less pain, and others, are further expected to propel the demand for clinical diagnostic tests market. According to the World Health Organization (WHO), 17.9 million people die each year due to cholesterol-related cardiac disorders, accounting for 31% of all deaths across the globe. Data reported by the American Heart Association indicates that about 2,300 Americans die of cardiovascular disease each day, an average of 1 death every 38 seconds.

Infectious diseases, on the other hand, are considered to be the leading causes of deaths across the world. According to the World Health Organization, lower respiratory infections remained the most deadly communicable diseases that caused 3.0 million deaths in 2017 globally. Growing patient awareness towards the importance of clinical diagnostic tests and the availability of cost-effective diagnostic tests related to chronic infectious diseases such as AIDS and hepatitis C will drive the demand for these tests in the market.

Segment Insights

Based on the type, the market is segmented into lipid Profile, metabolic testing, infectious Disease Testing, liver profiling, renal profiling, complete blood count, electrolyte testing, therapeutic drug monitoring, and others.

Clinical-Diagnostics-Market-Segmental-Insights

Lipid-Profiling — The Fastest-Growing Segment

Lipid profiling is expected to be the fastest-growing test segment, owing to the increasing demand for clinical tests such as total cholesterol, HDL cholesterol, triglycerides, LDL cholesterol, cholesterol/HDL Ratio, non-HDL cholesterol. A lipid profiling test measures the level of specific lipids in blood in order to evaluate the risk of cardiovascular disease (CVD) for patients, and it is widely used in clinical diagnostic laboratories to identify the patients with a high risk of developing a cardiac disorder. One of the primary causes of coronary heart disease is the accumulation of cholesterol on arterial walls, creating plaques, causing angina (chest pain), shortness of breath, myocardial infarction, or heart attack. As per the WHO, Coronary heart disease is now the leading cause of death across the world — an estimated 3.8 million men and 3.4 million women death reported each year due to coronary heart disease.

Molecular Diagnostic Testing R&D Emphasis to Drive the Reagents Segment’s Growth

The reagents segment is expected to gain significant market share, owing to the rising number of R&D initiatives associated with molecular diagnostic testing and other clinical diagnostic tests. Also, the increasing demand for self-test and point of care products are expected to maintain the market position of this segment during the forecast period. The segment is estimated to exhibit a lucrative CAGR over the forecast period.

Analytical instruments include machines and equipment that enable automation as well as combine samples and reagents used in the clinical diagnostics market. High throughput instruments like PCR are foreseen to gain substantial market share for the detection and quantification of infectious microorganisms, viral load, and blood antigens.

Impact of COVID 19

The outbreak of coronavirus has been increasing over the past few days, and there is an urgent need for accurate clinical diagnostic methods for the effective treatment of coronavirus. The availability of functional and practical COVID-19 clinical diagnostic kits in some countries is yet to be made, and the race to stop the spread has been taken up by global governments on war-footing. This is expected to impact positively on the clinical diagnostics market, particularly the infectious disease testing segment. The U.S. based ‘Ortho Clinical Diagnostics’ has launched an immunodiagnostic kit to detect antibodies (including IgG and IgM) to SARS-CoV-2 that can be used to detect immune response to the virus.

Regional Insights

Geographically clinical diagnostics market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.

North-Amercia-Lead-Clinical-Diagnostics-Market

The Prevalence of Chronic Diseases and Technological Advancements in North America

North America region dominates the clinical diagnostic market due to the rise in incidences and the prevalence of chronic diseases, technological advancements in clinical testing techniques, and the increase in healthcare expenditure Clinical diagnostic testing has made its place in regular medical practice and has expanded to all the levels of healthcare systems, from laboratories to the physician’s clinics and pathological laboratories. Although it has occupied place routine check-ups, its growth is driven by high-performance clinical technologies such as automated instruments and innovation in lower-cost clinical tests. According to the American Clinical Laboratory Association, from 2003 to 2013, CLFS pricing has been frozen or cut, which is driving the clinical diagnostic market in the North America region.

Asia-Pacific’s Rising Pollution Level Leading to Increased Chronic Disease Rate

Asia-Pacific is projected to witness the highest growth rate for the clinical diagnostic market, owing to the region’s inclination toward technological advancements, and the rising investments in clinical testing done by the global market players. The increasing pollution levels in emerging countries like India have made the country prone to chances of chronic diseases, which has resulted in the growing demand for diagnostic services and preventive care. India has witnessed significant technological advancements in the diagnostic sector, and it is evolving very rapidly in India, which can further strengthen the clinical diagnostic market in the healthcare system. In 2018, India’s first portable diagnostic solution, the iQuant immunoassay analyzer, launched by J. Mitra in the Indian market, in collaboration with Healthcare Technology Innovation Centre of IIT Madras, offers cost-effective clinical diagnostic solutions in remote regions and limited-resource healthcare settings.

Competitive landscape

The clinical diagnostics market is highly competitive and consists of global as well as regional players. Some of the key players in the market include Roche Diagnostics, Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., BioMérieux, Danaher Corporation, Qiagen, Thermo Fisher Scientific Inc., Sysmex Corporation, Charles River Laboratories, Quest Diagnostics Inc., Bioscientia Healthcare and others. With the increasing technological advances in clinical diagnostics, more companies are expected to penetrate the market in the coming future.

Recent Developments

  • In November 2019, Roche diagnostics and GE healthcare entered into a partnership agreement to develop an integrated digital diagnostics platform to improve oncology and critical care treatment.
  • In June 2019, QIAGEN diagnostics and DiaSorin Italy based clinical diagnostic laboratory collaborated to offer fully automated tuberculosis detection QuantiFERON TB gold plus analyzer system.

Clinical Diagnostics Market Segmentation

By Type of Tests

  • Lipid Profile
  • Metabolic testing
  • Infectious Disease Testing
  • Liver profiling
  • Renal profiling
  • Complete blood count
  • Electrolyte testing
  • Therapeutic drug monitoring
  • Others

By Product

  • Instruments
  • Reagents
  • Assays and Kits
  • Software
  • Others

By End-User

  • Hospital
  • Diagnostic Laboratory
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Frequently Asked Questions (FAQs)

The global clinical diagnostics market size was valued at USD 50,025 million in 2019 and is expected to expand at a CAGR of 6.5 % during the forecast period, 2020–2029.
Lipid-Profiling Type of Test Segment is expected to be the leading segment in Clinical Diagnostics Market during the forecast period.
North America is expected to hold the highest market share in Clinical Diagnostics Market.
Roche Diagnostics, Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., BioMérieux, Danaher Corporation, Qiagen, Thermo Fisher Scientific Inc. are the top players in Clinical Diagnostics Market.
In 2019 Global Clinical Diagnostics Market was valued at USD 50,025 million.
The rise in incidences and the prevalence of chronic diseases, technological advancements in clinical testing techniques, and the increase in healthcare expenditure are the key factors expected to drive Clinical Diagnostics Market during the forecast period.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times and included in every purchase.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.

Market Overview

Clinical diagnostics include medical tests carried out in pathology or diagnostic laboratory or hospital or in some other medical facility for the assessment or detection of any disease or other medical conditions. These clinical test results support in the early detection of illness and diagnose the associated risk factors while providing prevention and treatment prospects. The global market for clinical diagnostics is expected to grow at a considerable pace during the forecast period. Clinical diagnostic testing includes all routine check-ups, and other pathological examinations for diagnosis of diseases, ranging from complete blood count (CBC) tests to anatomical, physiological, molecular, and immunological and drug testing for disease diagnosis and early treatment intervention.

The global clinical diagnostics market size was valued at USD 50,025 million in 2019 and is expected to expand at a CAGR of 6.5 % during the forecast period, 2020–2029.

Global-Clinical-Diagnostics-Market

Market Drivers

An Array of Clinical Tests  — The Market Driver

A wide variety of clinical tests strengthens the ability of health care professionals to diagnose disease progress and often include blood and urine testing ranging from simple to complex genetic testing of molecular expression and various biochemical testing. There are more than 4,000 diagnostic tests available today and have been categorized into lipid profiling, complete blood count, HbA1c tests, HGB/HCT, Creatinine estimation, liver profiling, electrolytes testing, allergy profile testing, basic and comprehensive metabolic tests, and renal profile tests. Clinical testing laboratories offer these tests and services to meet the needs of the medical industry.

The Prevalence of Chronic Diseases

The clinical diagnostics market is primarily driven by the increasing prevalence of diseases caused due to sedentary lifestyles such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, and others. Furthermore, an increase in the number of patients suffering from kidney diseases and cancer is also expected to impact positively on the clinical diagnostics market during the forecast years. Additionally, benefits such as quick test results, easy procedure of testing, ease of procurement of samples, less pain, and others, are further expected to propel the demand for clinical diagnostic tests market. According to the World Health Organization (WHO), 17.9 million people die each year due to cholesterol-related cardiac disorders, accounting for 31% of all deaths across the globe. Data reported by the American Heart Association indicates that about 2,300 Americans die of cardiovascular disease each day, an average of 1 death every 38 seconds.

Infectious diseases, on the other hand, are considered to be the leading causes of deaths across the world. According to the World Health Organization, lower respiratory infections remained the most deadly communicable diseases that caused 3.0 million deaths in 2017 globally. Growing patient awareness towards the importance of clinical diagnostic tests and the availability of cost-effective diagnostic tests related to chronic infectious diseases such as AIDS and hepatitis C will drive the demand for these tests in the market.

Segment Insights

Based on the type, the market is segmented into lipid Profile, metabolic testing, infectious Disease Testing, liver profiling, renal profiling, complete blood count, electrolyte testing, therapeutic drug monitoring, and others.

Clinical-Diagnostics-Market-Segmental-Insights

Lipid-Profiling — The Fastest-Growing Segment

Lipid profiling is expected to be the fastest-growing test segment, owing to the increasing demand for clinical tests such as total cholesterol, HDL cholesterol, triglycerides, LDL cholesterol, cholesterol/HDL Ratio, non-HDL cholesterol. A lipid profiling test measures the level of specific lipids in blood in order to evaluate the risk of cardiovascular disease (CVD) for patients, and it is widely used in clinical diagnostic laboratories to identify the patients with a high risk of developing a cardiac disorder. One of the primary causes of coronary heart disease is the accumulation of cholesterol on arterial walls, creating plaques, causing angina (chest pain), shortness of breath, myocardial infarction, or heart attack. As per the WHO, Coronary heart disease is now the leading cause of death across the world — an estimated 3.8 million men and 3.4 million women death reported each year due to coronary heart disease.

Molecular Diagnostic Testing R&D Emphasis to Drive the Reagents Segment’s Growth

The reagents segment is expected to gain significant market share, owing to the rising number of R&D initiatives associated with molecular diagnostic testing and other clinical diagnostic tests. Also, the increasing demand for self-test and point of care products are expected to maintain the market position of this segment during the forecast period. The segment is estimated to exhibit a lucrative CAGR over the forecast period.

Analytical instruments include machines and equipment that enable automation as well as combine samples and reagents used in the clinical diagnostics market. High throughput instruments like PCR are foreseen to gain substantial market share for the detection and quantification of infectious microorganisms, viral load, and blood antigens.

Impact of COVID 19

The outbreak of coronavirus has been increasing over the past few days, and there is an urgent need for accurate clinical diagnostic methods for the effective treatment of coronavirus. The availability of functional and practical COVID-19 clinical diagnostic kits in some countries is yet to be made, and the race to stop the spread has been taken up by global governments on war-footing. This is expected to impact positively on the clinical diagnostics market, particularly the infectious disease testing segment. The U.S. based ‘Ortho Clinical Diagnostics’ has launched an immunodiagnostic kit to detect antibodies (including IgG and IgM) to SARS-CoV-2 that can be used to detect immune response to the virus.

Regional Insights

Geographically clinical diagnostics market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.

North-Amercia-Lead-Clinical-Diagnostics-Market

The Prevalence of Chronic Diseases and Technological Advancements in North America

North America region dominates the clinical diagnostic market due to the rise in incidences and the prevalence of chronic diseases, technological advancements in clinical testing techniques, and the increase in healthcare expenditure Clinical diagnostic testing has made its place in regular medical practice and has expanded to all the levels of healthcare systems, from laboratories to the physician’s clinics and pathological laboratories. Although it has occupied place routine check-ups, its growth is driven by high-performance clinical technologies such as automated instruments and innovation in lower-cost clinical tests. According to the American Clinical Laboratory Association, from 2003 to 2013, CLFS pricing has been frozen or cut, which is driving the clinical diagnostic market in the North America region.

Asia-Pacific’s Rising Pollution Level Leading to Increased Chronic Disease Rate

Asia-Pacific is projected to witness the highest growth rate for the clinical diagnostic market, owing to the region’s inclination toward technological advancements, and the rising investments in clinical testing done by the global market players. The increasing pollution levels in emerging countries like India have made the country prone to chances of chronic diseases, which has resulted in the growing demand for diagnostic services and preventive care. India has witnessed significant technological advancements in the diagnostic sector, and it is evolving very rapidly in India, which can further strengthen the clinical diagnostic market in the healthcare system. In 2018, India’s first portable diagnostic solution, the iQuant immunoassay analyzer, launched by J. Mitra in the Indian market, in collaboration with Healthcare Technology Innovation Centre of IIT Madras, offers cost-effective clinical diagnostic solutions in remote regions and limited-resource healthcare settings.

Competitive landscape

The clinical diagnostics market is highly competitive and consists of global as well as regional players. Some of the key players in the market include Roche Diagnostics, Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., BioMérieux, Danaher Corporation, Qiagen, Thermo Fisher Scientific Inc., Sysmex Corporation, Charles River Laboratories, Quest Diagnostics Inc., Bioscientia Healthcare and others. With the increasing technological advances in clinical diagnostics, more companies are expected to penetrate the market in the coming future.

Recent Developments

  • In November 2019, Roche diagnostics and GE healthcare entered into a partnership agreement to develop an integrated digital diagnostics platform to improve oncology and critical care treatment.
  • In June 2019, QIAGEN diagnostics and DiaSorin Italy based clinical diagnostic laboratory collaborated to offer fully automated tuberculosis detection QuantiFERON TB gold plus analyzer system.

Clinical Diagnostics Market Segmentation

By Type of Tests

  • Lipid Profile
  • Metabolic testing
  • Infectious Disease Testing
  • Liver profiling
  • Renal profiling
  • Complete blood count
  • Electrolyte testing
  • Therapeutic drug monitoring
  • Others

By Product

  • Instruments
  • Reagents
  • Assays and Kits
  • Software
  • Others

By End-User

  • Hospital
  • Diagnostic Laboratory
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Frequently Asked Questions (FAQs)

The global clinical diagnostics market size was valued at USD 50,025 million in 2019 and is expected to expand at a CAGR of 6.5 % during the forecast period, 2020–2029.
Lipid-Profiling Type of Test Segment is expected to be the leading segment in Clinical Diagnostics Market during the forecast period.
North America is expected to hold the highest market share in Clinical Diagnostics Market.
Roche Diagnostics, Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., BioMérieux, Danaher Corporation, Qiagen, Thermo Fisher Scientific Inc. are the top players in Clinical Diagnostics Market.
In 2019 Global Clinical Diagnostics Market was valued at USD 50,025 million.
The rise in incidences and the prevalence of chronic diseases, technological advancements in clinical testing techniques, and the increase in healthcare expenditure are the key factors expected to drive Clinical Diagnostics Market during the forecast period.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times and included in every purchase.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.